Home Navidea Biopharmaceuticals Downgraded by Zacks to "Sell"
 

Keywords :   


Navidea Biopharmaceuticals Downgraded by Zacks to "Sell"

2015-10-11 15:25:58| Biotech - Topix.net

According to Zacks, "Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents for diseases such as cancer and Alzheimer. The Company's radiopharmaceutical development programs include: Lymphoseek , AZD4694 and RIGScan .

Tags: sell downgraded zacks biopharmaceuticals

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.10Weekly Recap: BASF, Beckers, Allnex, Sherwin-Williams Top This Weeks Stories
05.10Hurricane Kirk Graphics
05.10Hurricane Kirk Forecast Discussion Number 24
05.10Hurricane Kirk Wind Speed Probabilities Number 24
05.10Hurricane Kirk Forecast Advisory Number 24
05.10Hurricane Kirk Public Advisory Number 24
05.10Summary for Hurricane Kirk (AT2/AL122024)
05.10Hurricane Leslie Graphics
More »